Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/12813
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPinto, Cristhiane-
dc.contributor.authorFreitas, Renata de-
dc.contributor.authorTutungi, Margarida-
dc.contributor.authorBurburan, Shirley Moreira-
dc.date.accessioned2023-02-15T19:03:48Z-
dc.date.available2023-02-15T19:03:48Z-
dc.date.issued2009-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/12813-
dc.description.abstractThe dyspnea is defined as: "Feeling uncomfortable in the act of breathing" and is one of the most prevalent and devastating symptoms in patients with advanced cancer, independent of the primary site of the disease. It one of refractory symptoms most commonly associated with the progressive loss in quality of life about 70% of patients with advanced cancer present some degree of dyspnea in the last six weeks of life. The Morphine is one of the best medicines for the treatment of terminal dyspnea; it reduces the discomfort and increases the tolerance to hypoxia and hypercapnia.pt_BR
dc.titleUse of Morphine to Control Terminal Dyspnea in a Palliative Care Unit in Brazilpt_BR
dc.TypeOtherpt_BR
Appears in Collections:Pôsteres publicados pela Área de Edição e Produção de Materiais Técnico-científicos

Files in This Item:
File Description SizeFormat 
Use of Morphine to Control Terminal Dyspnoea in a Palliative Care Unit in Brazil. 2009..pdf1.29 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.